| P50 | author | Bouke P Hazenberg | Q57219791 |
| | Walter Noordzij | Q88510763 |
| | Andor W J M Glaudemans | Q91190461 |
| P2093 | author name string | Rudi A J O Dierckx | |
| | Riemer H J A Slart | |
| P2860 | cites work | Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis | Q24562844 |
| | Localized AL amyloidosis: a suicidal neoplasm? | Q27692643 |
| | Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene | Q28246156 |
| | Intestinal amyloidosis: two cases with different patterns of clinical and imaging presentation | Q33879496 |
| | Antibodies to human serum amyloid P component eliminate visceral amyloid deposits | Q34144814 |
| | Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis | Q34147275 |
| | Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. | Q34437074 |
| | Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis | Q34977930 |
| | Molecular mechanisms of amyloidosis | Q35194628 |
| | 18F-FDG PET/CT in primary AL hepatic amyloidosis associated with multiple myeloma | Q35201749 |
| | 18F-FDG PET/CT in patients with amyloid light-chain amyloidosis: case-series and literature review | Q38010222 |
| | The systemic amyloidoses | Q41596634 |
| | Findings of pulmonary amyloidosis on dual phase FDG PET/CT imaging | Q43154909 |
| | Pulmonary amyloidosis mimicking multiple metastatic lesions on F-18 FDG PET/CT. | Q43215017 |
| | Intense fluorodeoxyglucose activity in pulmonary amyloid lesions on positron emission tomography | Q44685242 |
| | False-positive FDG positron emission tomography in pulmonary amyloidosis | Q45057504 |
| | Incidental detection of concurrent extramedullary plasmacytoma and amyloidoma of the nasopharynx on [18F]fluorodeoxyglucose positron emission tomography/computed tomography | Q46253118 |
| | Pulmonary amyloidosis: detection with PET-CT. | Q46488277 |
| | Lymphadenopathy due to amyloidosis secondary to Sjögren syndrome and systemic lupus erythematosus detected by F-18 FDG PET. | Q46854027 |
| | Visualization of amyloid arthropathy in light-chain systemic amyloidosis on F-18 FDG PET/CT scan. | Q53255335 |
| | Pulmonary amyloid and PET scanning. | Q53581933 |
| | Amyloidosis | Q56336554 |
| | Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value | Q74449400 |
| | What is the role of giant cells in AL-amyloidosis? | Q78103434 |
| | Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis | Q82970801 |
| | Tracheobronchial FDG uptake in primary amyloidosis detected by PET/CT | Q84472279 |
| | Fixed digital contractures revealing light-chain amyloidosis | Q84623484 |
| P433 | issue | 7 | |
| P921 | main subject | Fluorodeoxyglucose Positron Emission Tomography | Q130273243 |
| P304 | page(s) | 1095-1101 | |
| P577 | publication date | 2013-03-09 | |
| P1433 | published in | European Journal of Nuclear Medicine and Molecular Imaging | Q15708890 |
| P1476 | title | Utility of 18F-FDG PET(/CT) in patients with systemic and localized amyloidosis | |
| P478 | volume | 40 | |